GLP-1s, Personalization, and Big Pharma Power Plays: What's Really at Stake in the Eli Lilly Lawsuit - MedCity News
The future of medicine will be personalized, taking patients' specific medical history into account when prescribing care. Hand-tailored treatment plans are especially crucial for issues as nuanced as obesity.
Patients Are Left With Few Options as GLP-1 Copycats Disappear
Access to weight loss medications like Ozempic and Zepbound is uncertain for many as compounded versions exit the market with drug supply stabilization.
Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss
GLP-1 agonists like Ozempic and Wegovy offer extensive health benefits beyond weight loss, affecting various disorders including addiction, Alzheimer's, and psychosis.
Thanksgiving on Ozempic: 5 rules for eating and dosing during the holidays
GLP-1 medications like Ozempic and Wegovy have skyrocketed in popularity for weight management, helping to manage appetite without disrupting holiday enjoyment.